Webinar

Advances in cellular reprogramming: from stem cells to printed tissues

A scalable technology platform capable of producing consistent batches of every human cell has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease.
Advances in cellular reprogramming: from stem cells to printed tissues

Prof Hagan Bayley

Professor of Chemical Biology

University of Oxford

Advances in cellular reprogramming: from stem cells to printed tissues
A scalable technology platform capable of producing consistent batches of every human cell has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease.
Advances in cellular reprogramming: from stem cells to printed tissues

Prof Hagan Bayley

Professor of Chemical Biology

University of Oxford

This webinar discusses

  • Today’s challenges in CNS research, disease modelling and drug discovery: limited access to reliable human models.
  • How a novel cellular reprogramming technology, opti-ox™, resolves the inconsistency of cellular reprogramming and enables the precise, consistent, and scalable production of human cells.
  • The fabrication of synthetic, printed and hybrid materials, and their applications.

Prof Hagan Bayley | Professor of Chemical Biology | University of Oxford

Dr Mark Kotter | Founder & CEO | bit.bio

2020

Watch webinar

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell identity coding platform behind our cells
Join us Explore the latest roles at bit.bio